Mashiro Okunaka, Momoka Furuoka, Masashi Wakabayashi, Hideki Furuya, Hideaki Bando, Kohei Shitara, Izuma Nakayama. "A randomized phase II clinical trial evaluating the safety and efficacy of initial dose adjustment of zolbetuximab plus chemotherapy in patients with HER2-negative and CLDN18.2-positive unresectable advanced or recurrent gastric, gastroesophageal junction cancer or esophageal adenocarcinoma (GENTLE-Z).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.tps504